Guerbet launches FlowSens contrast injection system

By AuntMinnie.com staff writers
March 7, 2014

Contrast agent manufacturer Guerbet has released its new FlowSens contrast injection system for use in CT scans.

The product has received the CE Mark and will initially be marketed in Belgium, France, Germany, and Switzerland, the company said. Guerbet presented FlowSens for the first time at ECR 2014 in Vienna.

FlowSens is designed for the injection of contrast agents and saline solution in CT exams, according to Guerbet. It features a hydraulic syringe-free injection system and is compatible with the company's ScanBag and all types of contrast agent available on the market.

Guerbet nets FDA OK for Lipiodol plant
French contrast agent developer Guerbet has received approval from the U.S. Food and Drug Administration for a new manufacturing plant for Lipiodol (ethiodized...
Guerbet takes aim at U.S. with launch of Dotarem MRI contrast
French contrast agent developer Guerbet isn't exactly a household name in the U.S., but the company hopes this will change with the launch this summer...
FDA approves Guerbet's Dotarem MRI contrast
French contrast developer Guerbet has received approval for its Dotarem (gadoterate meglumine) MRI contrast agent from the U.S. Food and Drug Administration.
FDA panel OK's NDA for Guerbet's Dotarem
Guerbet has received a unanimous recommendation from the U.S. Food and Drug Administration's Medical Imaging Drugs Advisory Committee that the agency...
MDS Nordion, Guerbet to develop PET agents
MDS Nordion has entered into a collaboration to develop new PET radiotracers for cancer diagnostics.

Copyright © 2014 AuntMinnie.com

Last Updated np 3/7/2014 2:57:26 PM